SCHEMBL25520895

SCHEMBL25520895

CCOC(CO)Cn1ccc(C)nc1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 3/20 0.52
SLC22A6 Q4U2R8 1/20 0.51
PKM P14618 1/20 0.43
TYMP P19971 1/20 0.37
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
CYP3A4 P08684 1/20 0.31
NFKB1 P19838 1/20 0.31
BLM P54132 1/20 0.31
VCP P55072 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HIF1A Q16665 1/20 0.31
HPRT1 P00492 1/20 0.31
HSD17B10 Q99714 1/20 0.31
KDM4E B2RXH2 2/20 0.30
POLB P06746 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14450629 0.85 FGFR1 (0.56) FGFR1SLC22A6PKMTYMPMAPT
SCHEMBL25521527 0.85 FGFR1 (0.71) FGFR1SLC22A6PKMTYMPMAPT
SCHEMBL15046004 0.85 FGFR1 (0.71) FGFR1SLC22A6PKMTYMPMAPT
SCHEMBL13799139 0.84 FGFR1 (0.74) FGFR1SLC22A6PKMTYMPCYP3A4
SCHEMBL15354006 0.77 FGFR1 (0.62) FGFR1SLC22A6TYMPCYP3A4HPRT1
SCHEMBL14450620 0.75 TSHR (0.38) FGFR1SLC22A6PKMMAPTKMT2A
SCHEMBL13799136 0.75 FGFR1 (0.46) FGFR1SLC22A6PKMTYMP
SCHEMBL14450632 0.75 FGFR1 (0.44) FGFR1SLC22A6PKMTYMP
SCHEMBL1105225 0.74 FGFR1 (0.45) FGFR1SLC22A6TYMPKMT2AMEN1
SCHEMBL26772786 0.73 FGFR1 (0.65) FGFR1SLC22A6TYMPCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159574-A1 BENZYLOXY PHOSPH(ON)ATE COMPOUNDS CITIBANK, N.A., AS ADMINISTRATIVE AGENT 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159574-A1 BENZYLOXY PHOSPH(ON)ATE COMPOUNDS PYGL, GOT2, ALPI FGFR1 2506/4885SLC22A6 1841/4885PKM 538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.